MRAI · Marpai, Inc.
$0.65
At close · May 29
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“management has determined that our liquidity condition raises substantial doubt about our ability to continue as a going concern through twelve months from the date these condensed consolidated financial statements are issued.”View the 10-Q filed Aug 13, 2026
Market Cap
$62.51M
Shares
26.83M
MRAI metrics
46 of 114 screener metrics currently available.
Market overview
2 metricsShare price
$0.65
Market cap
$62.51M
Price action
19 metricsPrice change (1W)
-67.5%
Price change (30D)
—
Price change (3M)
-56.1%
Price change (6M)
-71.2%
Price change (YTD)
-62.9%
Price change (1Y)
—
Trailing year
Price change (5Y)
—
52-week high
—
52-week low
—
Change from 52-week high
—
Change from 52-week low
—
Annualized volatility
197.9%
Beta
—
RSI (14D)
19.6
Price vs SMA 50
-70.2%
Price vs SMA 200
-55.5%
Avg volume (3M)
419,616
Relative volume
0.5
Average dollar volume
$836,839
Company
3 metricsSector
Healthcare
Industry
Healthcare Plans
Shares outstanding
26.83M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
5.0×
reciprocal yield 20.0%
EV / EBITDA
—
EV / EBIT
—
P / sales
3.8×
reciprocal yield 26.6%
P / book
—
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-27.0%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
1.0×
reciprocal yield 101.4%
EV / revenue historical average (5Y)
1.0×
reciprocal yield 101.4%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2025-11-12
Profitability
9 metricsGross margin
—
Operating margin
-81.8%
Trailing 12 months
Net margin
-101.5%
Gross profit (TTM)
—
Operating profit (TTM)
−$13.61M
Net income (TTM)
−$16.89M
Trailing 12 months
Diluted EPS (TTM)
$-0.77
FCF margin
—
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
-10.5%
Year over year
Net income growth YoY
—
Revenue (TTM)
$16.64M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+66.8%
Year over year · more shares
Revenue CAGR (3Y)
-9.4%
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
—
Return on assets
-178.4%
Debt / equity
—
Current ratio
0.4
EBITDA (TTM)
−$13.39M
Free cash flow (TTM)
—
Quick ratio
0.4
Interest coverage
-3.8
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
−$20.59M
Latest balance sheet
Cash & equivalents
$138,000
Total assets
$9.47M
Total debt
$20.73M
Cash flow & spend
7 metricsOperating cash flow (TTM)
−$8.71M
Capital expenditures (TTM)
—
R&D (TTM)
$29,000
SG&A (TTM)
—
Stock compensation (TTM)
$3.69M
R&D / revenue
—
Stock compensation / revenue
22.2%
Ownership (13F)
3 metrics13F filers
—
13F filer change QoQ
—
Institutional ownership
—
Short interest
3 metricsShort interest
—
Latest settlement
Days to cover
—
Short-squeeze score
—
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
Flagged